Polygenic Embryo Screening: Where Do We Stand? – ESHRE
European Society of Human Reproduction and Embryology (ESHRE) shared a post on LinkedIn:
“Polygenic Embryo Screening: Where Do We Stand?
Polygenic embryo screening (PES) can now assess IVF embryos for risks of heart disease, diabetes, schizophrenia and cancers. It’s already available, but highly controversial.
The disconnect: patients show strong interest – healthcare professionals have serious concerns.
Join this ESHRE webinar as international experts share new research on these diverging attitudes. Through focused presentations and panel discussion, we’ll explore:
- What drives patient demand vs. professional hesitation
- How views differ across cultures and demographics
- The implications for policy, education and patient care
Be part of shaping how we navigate this emerging frontier in hashtag#ReproductiveGenetics.
Date: 10 February 2026 | 17:00 CET
Find out more.”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Aug 13, 2026, 16:25Devyanshi Dixit: Building Healthier Futures Through Reproductive Health Education
-
Aug 13, 2026, 16:18Stephen Parker Ellington: An Encouraging Story for Fertility And Women’s Reproductive Choice
-
Aug 13, 2026, 16:09Kiani Davis: Fertility Patient Journey Series – Part 2
-
Aug 13, 2026, 16:02Lodovico Parmegiani: Live Births Following Universal Single-Step Warming Across Multiple Vitrification Systems
-
Aug 13, 2026, 15:51The Future of Women’s Health Begins With the Knowledge We Give Young People Today – GFWH 2026
-
Aug 13, 2026, 15:409 Affirmations from ECSACOG-CoP – FIGO
-
Aug 13, 2026, 15:29Devyanshi Dixit: Empowering Adolescents Through Reproductive and Menstrual Health Education
-
Aug 13, 2026, 15:23That’s a Wrap on the Fertility Society of Australia and New Zealand 2026 – Monash IVF Group
-
Aug 13, 2026, 15:18Devyanshi Dixit: Can Women Have Endometriosis Without Severe Pain?
